Ensol Biosciences Inc. (XKON:140610)
South Korea · Delayed Price · Currency is KRW 10,130
-70 (-0.69%)
At close: Sep 23, 2026
Ensol Biosciences Market Cap
Ensol Biosciences has a market cap or net worth of 145.63 billion as of September 25, 2026. Its market cap has decreased by -22.83% in one year.
Market Cap
145.63B
Enterprise Value
n/a
Revenue
537.46M
Ranking
n/a
PE Ratio
n/a
Stock Price
10,130.00
ChartMarket Cap Chart
Since September 10, 2018, Ensol Biosciences's market cap has increased from 106.21B to 145.63B, an increase of 37.12%. That is a compound annual growth rate of 4.00%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 23, 2026 | 145.63B | -17.06% |
| Dec 30, 2025 | 175.59B | -10.18% |
| Dec 30, 2024 | 195.49B | 264.72% |
| Dec 28, 2023 | 53.60B | -23.21% |
| Dec 29, 2022 | 69.80B | -47.06% |
| Dec 30, 2021 | 131.85B | 5.52% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Sep 10, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| curacle co.,ltd. | 212.04B |
| Kangstem Biotech | 193.75B |
| NIBEC | 173.70B |
| Bio Solution | 164.89B |
| Kanaph Therapeutics | 159.34B |
| ISU Abxis | 143.73B |
| TiumBio | 133.37B |
| Y-Biologics | 128.16B |